Current National Initiatives and Policies to Control Drug Costs in Europe: UK Perspective

Martin Duerden*, Narinder Gogna, Brian Godman, Kate Eden, Michael Mallinson, Nick Sullivan

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

10 Citations (Scopus)


Healthcare represents a significant proportion of UK government expenditure leading to the introduction of a number of reforms to contain costs while improving the quality and efficiency of care. Equity is also a core principle. These objectives have led to the institution of a number of central initiatives including National Institute for Clinical Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN), and the National Service Frameworks (NSFs). NICE has met with variable success, with a number of activities and measures proposed to enhance its contribution. Other measures recently instituted to improve quality and efficiency include risk sharing arrangements, prescribing incentive schemes coupled with academic detailing, and outcome guarantee schemes. Ongoing reforms will continue with an aging population and pressure on resources.

Original languageEnglish
Pages (from-to)132-138
Number of pages7
JournalJournal of Ambulatory Care Management
Issue number2
Publication statusPublished - 2004
Externally publishedYes


  • Health economics
  • Health technology
  • Prescribing


Dive into the research topics of 'Current National Initiatives and Policies to Control Drug Costs in Europe: UK Perspective'. Together they form a unique fingerprint.

Cite this